Hunan Jiudian Pharmaceutical Co., Ltd. Stock

Equities

300705

CNE1000034Z6

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
36.22 CNY +3.46% Intraday chart for Hunan Jiudian Pharmaceutical Co., Ltd. +4.96% +9.00%

Financials

Sales 2024 * 3.37B 465M 636M Sales 2025 * 4.18B 577M 789M Capitalization 12.5B 1.73B 2.36B
Net income 2024 * 502M 69.28M 94.72M Net income 2025 * 649M 89.57M 122M EV / Sales 2024 * 3.71 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.99 x
P/E ratio 2024 *
24.9 x
P/E ratio 2025 *
19.2 x
Employees 1,636
Yield 2024 *
0.5%
Yield 2025 *
0.61%
Free-Float 48.72%
More Fundamentals * Assessed data
Dynamic Chart
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Elects Yang Yang and Fan Pengyun as Non-Independent Director CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Hunan Jiudian Pharmaceutical Co., Ltd.(XSEC:300705) added to S&P Global BMI Index CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Hunan Jiudian Pharma Wins Nod to Trial Anti-Inflammatory Patch MT
Jiudian Pharma Sees FY22 Profit to Rise Up to 33.7% MT
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Hunan Jiudian Pharmaceutical Co., Ltd. entered into an agreement to acquire Hunan Huiyang Information Technology Co., Ltd. from Duan Lixin and Duan Linong for CNY 8.56 million. CI
More news
1 day+3.46%
1 week+4.96%
Current month-3.52%
1 month-6.77%
3 months+18.52%
6 months+42.09%
Current year+9.00%
More quotes
1 week
33.08
Extreme 33.08
36.73
1 month
33.08
Extreme 33.08
37.55
Current year
27.68
Extreme 27.68
39.00
1 year
18.80
Extreme 18.8
39.00
3 years
13.14
Extreme 13.1357
39.00
5 years
6.85
Extreme 6.85
39.00
10 years
4.44
Extreme 4.4429
39.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 02-12-31
Director of Finance/CFO 60 06-12-31
Director/Board Member 47 00-12-31
Members of the board TitleAgeSince
Chairman 61 00-12-31
Director/Board Member 60 00-12-31
Director/Board Member 57 00-12-31
More insiders
Date Price Change Volume
24-04-26 36.22 +3.46% 5,236,342
24-04-25 35.01 +2.67% 7,675,592
24-04-24 34.1 -1.33% 3,023,474
24-04-23 34.56 -4.24% 4,832,800
24-04-22 36.09 +4.58% 2,584,185

End-of-day quote Shenzhen S.E., April 25, 2024

More quotes
Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Company’s products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
36.22
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300705 Stock